These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 15127371)
61. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients]. Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662 [TBL] [Abstract][Full Text] [Related]
62. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. Jernigan DB; Cetron MS; Breiman RF JAMA; 1996 Jan; 275(3):206-9. PubMed ID: 8604173 [TBL] [Abstract][Full Text] [Related]
63. [Invasive pneumococcal diseases in children and surveillance systems in Italy]. Bagnato B; Marino MG; Franco E Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089 [TBL] [Abstract][Full Text] [Related]
64. Drug-resistant Streptococcus pneumoniae in a day care population. Bavaro MF; Catbagan AC; Tasker SA; Gray DE; Waecker NJ; Wallace MR Clin Infect Dis; 2002 Apr; 34(8):1164. PubMed ID: 11915016 [No Abstract] [Full Text] [Related]
65. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. Reechaipichitkul W; Assawasanti K; Chaimanee P Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993 [TBL] [Abstract][Full Text] [Related]
66. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease. Pérez-Trallero E; Marimón JM; González A; Ercibengoa M; Larruskain J Clin Infect Dis; 2005 Aug; 41(4):560-4. PubMed ID: 16028169 [TBL] [Abstract][Full Text] [Related]
67. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP; Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622 [TBL] [Abstract][Full Text] [Related]
69. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia. Martynova AV; Turcutyuicov VB Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139 [No Abstract] [Full Text] [Related]
70. [Pneumococcal infections -- clinical features, prevention and current therapy. Interview with Dr. Endre Ludwig by Anna Radnai]. Ludwig E Orv Hetil; 2013 Jan; 154(3):118-20. PubMed ID: 23315227 [No Abstract] [Full Text] [Related]
71. Clinical impact of antibiotic resistance in respiratory tract infections. Klugman KP Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654 [TBL] [Abstract][Full Text] [Related]
72. [Various prospective approaches to the treatment of nonspecific lung diseases]. Sil'vestrov VP; Vanina NF Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837 [No Abstract] [Full Text] [Related]
73. The role of Pneumococcal vaccine. Braido F; Bellotti M; De Maria A; Cazzola M; Canonica GW Pulm Pharmacol Ther; 2008 Aug; 21(4):608-15. PubMed ID: 18502670 [TBL] [Abstract][Full Text] [Related]
74. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. Ross JJ; Worthington MG; Gorbach SL N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545 [No Abstract] [Full Text] [Related]
75. Pharmacotherapy for pneumococcal infections: an update. Esposito S; Principi N Expert Opin Pharmacother; 2013 Jan; 14(1):65-77. PubMed ID: 23256539 [TBL] [Abstract][Full Text] [Related]